DNA Repair 6 , 17091725 (2007)
Song C, Vandewoude M, Stevens W, De Clerck L, Van der Planken M, Whelan A, et al
If your symptoms persist or worsen, consult your healthcare provider for guidance
Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors not yet licensed by the MHRA or EMA for use in the UK
doi: 10.1016/J.TRANON.2021.101281 251 HaghmoradDRazaviFTEivazzadehYYazdanpanahEOroojiN
La tirzepatida ha demostrado en ensayos clnicos una mayor prdida de peso y mejor control metablico que la semaglutida, resume a SINC Mara Josefa Garca Barrado , profesora de farmacologa de la Universidad de Salamanca, especializada en neuroendocrinologa y obesidad